Wilson Sonsini Goodrich & Rosati advised Khosla Ventures on the transaction. Vivodyne announced the close of $38 million in total seed financing, led by Khosla Ventures, with...
Vivodyne’s $38 Million Seed Financing Round
Nature’s Toolbox’s $47.5 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Nature’s Toolbox on the transaction. Nature’s Toolbox (NTx) announced the close of a $47.5 million Series B funding round led by...
Divergent Technologies’ $230 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati advised Divergent on the transaction. Divergent Technologies, Inc. announced the closing of its Series D equity financing totaling $230 million. The round...
Arcellx’s Expansion of Partnership with Kite
Wilson Sonsini Goodrich & Rosati is advising Arcellx on the transaction. Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD) announced that they have...
Melinta Therapeutics’ Licensing Agreement with Venatorx Pharmaceuticals
Wilson Sonsini Goodrich & Rosati advised Venatorx on IP matters in the transaction. Melinta Therapeutics LLC (Melinta) and Venatorx Pharmaceuticals, Inc. (Venatorx), announced that they have...
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
Alector’s $125 Million At-The-Market Offering
Wilson Sonsini Goodrich & Rosati represented Alector, Inc. in the offering, and Davis Polk & Wardwell represented TD Cowen, as sales agent. Alector, Inc. (“Alector”) (Nasdaq:ALEC)...
CARGO Therapeutics’ $281.3 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
Sony Interactive Entertainment’s Acquisition of iSIZE
Wilson Sonsini Goodrich & Rosati advised iSIZE on the transaction. Sony Interactive Entertainment (SIE) announced that it had entered into an agreement to acquire iSIZE Limited, a...
BibliU’s Acquisition of Texas Book Company
Wilson Sonsini Goodrich & Rosati advised BibliU on the transaction. BibliU announced the acquisition of Texas Book Company, a privately held company in Texas. This acquisition...
Celest Therapeutics’ Collaboration with Senti Biosciences
Wilson Sonsini Goodrich & Rosati represented Celest Therapeutics in the transaction. Celest Therapeutics (Shanghai) Co. Ltd (“Celest”) announced a collaboration with Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti...
Alpine Immune Sciences’ $150 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...